QT interval prolongation by noncardiovascular drugs: A proposed assessment strategy
- 1 June 1999
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 47 (2) , 55-62
- https://doi.org/10.1002/(sici)1098-2299(199906)47:2<55::aid-ddr1>3.0.co;2-3
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium currentNature, 1996
- Drug-Induced Torsade de PointesDrug Safety, 1994
- Potassium channel blockers as antiarrhythmic drugsDrug Development Research, 1994
- Rate-corrected QT interval: Techniques and limitationsThe American Journal of Cardiology, 1993
- Effects of bepridil and diltiazem on ventricular repolarization in angina pectorisThe American Journal of Cardiology, 1990
- Quinidine-induced long qtu interval and torsade de pointes: Role of bradycardia-dependent early afterdepolarizationsJournal of the American College of Cardiology, 1989
- QTU prolongation and polymorphic ventricular tachyarrhythmias due to bradycardia-dependent early afterdepolarizations. Afterdepolarizations and ventricular arrhythmias.Circulation Research, 1988
- In vitro validation of a new cardiac catheter technique for recording monophasic action potentialsEuropean Heart Journal, 1986
- Polymorphous Ventricular Tachycardia Associated with a Marked Prolongation of the Q-T Interval Induced by AmiodaronePacing and Clinical Electrophysiology, 1984
- Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugsThe American Journal of Cardiology, 1976